Clinigen educates on early access to rare disease therapies
Ginkgo Bioworks scales up again with M&A frenzy
Power of digital technology and partnership to accelerate delivery of new medicines to patients
Viatris splashes out $350m on pair of Idorsia therapies
AbbVie inks $713m deal for OSE chronic inflammation drug
Rare Disease Day: Enhancing clinical trial success in rare diseases
PHTI to review digital hypertension, mental health tools
Janux plans $200m offer on back of prostate cancer readout
Minerva slumps as FDA finds fault with schizophrenia filing
Europe’s commercial leaders prepare for a faster trial-to-treatment pathway
Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions
Viva in vivo: The next generation of cell therapy is fast ap...
Cell therapy is a field rife with innovation, but most of the novel therapies being developed fall into one of two basic categories: autologous cell therapies, which involve removing a pati
Enabling site success: Key insights to reducing burden and i...
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Less than three weeks away: Join Global Experts at Transderm...
11-12 November 2024 in London, UK
4th mRNA Analytical Development & Quality Control Summit | F...
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.